Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy
- 31 December 2010
- journal article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 101 (4), 332-337
- https://doi.org/10.1016/j.ymgme.2010.07.011
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Identifying the Etiology: A Systematic Approach Using Delayed-Enhancement Cardiovascular Magnetic ResonanceHeart Failure Clinics, 2009
- Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe diseaseGenetics in Medicine, 2008
- Cardiac Remodeling After Enzyme Replacement Therapy with Acid α-Glucosidase for Infants with Pompe DiseasePediatric Cardiology, 2008
- Twenty‐four‐month α‐galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parametersJournal of Inherited Metabolic Disease, 2008
- Enhanced Response to Enzyme Replacement Therapy in Pompe Disease after the Induction of Immune ToleranceAmerican Journal of Human Genetics, 2007
- Cardiac magnetic resonance in myocardial diseaseHeart, 2006
- Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe diseaseThe Journal of Pediatrics, 2006
- Impact of Enzyme Replacement Therapy on Cardiac Morphology and Function and Late Enhancement in Fabry’s CardiomyopathyThe American Journal of Cardiology, 2006
- Prevalence and Clinical Significance of Cardiac Arrhythmia in Anderson-Fabry DiseaseThe American Journal of Cardiology, 2005
- Pompe disease in infants and childrenThe Journal of Pediatrics, 2004